Speakers

Thomas Areschoug

Chief Business Officer

Targinta

Tangsheng Yi

Director

Inflammation/ Immunology Gilead

Bruce Rogers

President

Morphic Therapeutics

Stephen Nishimura

Professor

UCSF

Gregory Bix

Professor

Tulane University

Bernhard Wehrle-Haller

Professor

Geneva University

Upendra Marathi

President & CEO

7 Hills Pharma

Darren G. Woodside

Vice President of Research

Texas Heart Institute

Dermot Cox

Associate Professor Pharmacy & Biomolecular Sciences

Royal College of Surgeons, Ireland

Eric Lefevbre

Chief Medical Officer

Pliant Therapeutics

Kevin Hart

Senior Principal Scientist

Pfizer

Peter Vanderslice

Co-Founder

7 Hills Pharma

Scott Edwards

Chief Development Operating Officer

OcuTerra Therapeutics

Scott Turner

Senior Vice President of Research

Pliant Therapeutics

Evy LundgrenÅkerlund

Chief Executive Officer

Xintela

Shaker Mousa

Professor ACPHS and Co-Founder

Nano-Pharmaceuticals

Horst Kessler

Professor

Technical University Munich

Riccardo Canevari

Chief Executive Officer

Radiopharm Theranostics

Natalia Blanco

Associate Director, Immuo-Oncology

Morphic Therapeutics

Abhishek Jha

CEO & Co-Founder

Elucidata